BRIEF published on 04/24/2024 at 14:05, 1 year 7 months ago OBMI Expands with New Office Launch in London European Expansion OBMI Architectural Innovation Luxury Hospitality Design London Office
PRESS RELEASE published on 04/24/2024 at 14:00, 1 year 7 months ago OBMI Announces New Office in London Luxury hospitality design firm OBMI expands its international footprint with a new office in London. The office in Chancery House will focus on European hospitality development Luxury Strategic Expansion OBMI Hospitality Design London Office
BRIEF published on 03/28/2024 at 15:35, 1 year 8 months ago OBMI Announces New Managing Director for Miami Office Miami Design Excellence OBMI Mauro Comoli Hospitality Design
PRESS RELEASE published on 03/28/2024 at 15:30, 1 year 8 months ago OBMI Appoints Mauro Comoli as Managing Director for Miami Office Mauro Comoli has been appointed Managing Director of OBMI's Miami office, overseeing strategic guidance for premier hospitality design projects worldwide Managing Director Miami OBMI Mauro Comoli Hospitality Design
Published on 12/05/2025 at 02:35, 2 hours ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 35 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 30 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 35 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 5 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 44 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 10 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 20 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 24 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 35 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 50 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 51 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 34 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
